Join
Live feed
·
INSIDERFilingvia Quantisnow
Cara Therapeutics Inc. logo

Maynard Ryan D sold $2,909 worth of shares (5,488 units at $0.53), decreasing direct ownership by 41% to 8,012 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CARA· Cara Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CARA (Cara Therapeutics Inc.) and more on Quantisnow.